Allelic imbalance and microsatellite instability in resected Duke's D colorectal cancer

Diagnostic Molecular Pathology

Volumn 6, Issue 2, 1997, Pages 78-84

  Kochhar, Ruby ^a   Halling, Kevin C ^a   McDonnell, Shannon ^a   Schaid, Daniel J ^a   French, Amy J ^a   O'Connell, Michael J ^a   Nagorney, David M ^a   Thibodeau, Stephen N ^a  

^a MAYO CLINIC   (United States)

Author keywords

Allelic imbalance; Colorectal cancer; Hepatic resection; Microsatellite instability

Indexed keywords

MICROSATELLITE DNA;

ADULT; AGED; ALLELE; ARTICLE; CHROMOSOME 17P; COLORECTAL CANCER; FEMALE; GENETIC STABILITY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER METASTASIS; LIVER RESECTION; MALE; MOLECULAR GENETICS; PRIORITY JOURNAL;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA; CHROMOSOMES, HUMAN, PAIR 17; COLORECTAL NEOPLASMS; DNA, SATELLITE; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MICROSATELLITE REPEATS; MIDDLE AGED;

EID: 0030909374     PISSN: 10529551     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019606-199704000-00002     Document Type: Article

References (31)

1. Aaltonen LA, Peltomaki P, Leach FS, et al. Clues to the pathogenesis of familial colorectal cancer. Science 1993; 260:812-6.
2. Adson MA. Resection of liver metastases: when is it worthwhile? World J Surg 1987;11:511-20.
3. Baker SJ, Fearon ER, Nigro JM, et al. Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science 1989;244:217-21.
4. Baker SJ, Preisinger AC, Jessup JM, et al. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990;50:7717-22.
5. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994;86:681-7.
6. Cunningham JM, Lust JA, Schaid DJ, et al. Expression of p53 and 17p allelic loss in colorectal carcinoma. Cancer Res 1992; 52:1974-80.
7. Diller L, Kassel J, Nelson CE, et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 1990; 10:5772-81.
8. Fearon ER, Cho KR, Nigro JM, et al. Identification of a chromosome 18q gene that is altered in colorectal cancers. Science 1990;247:49-56.
9. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-67.
10. French AJ, Moon-Tasson L, Hailing KC, McDonnell S, Schaid DJ, O'Connell MJ, Thibodeau SN. Microsatellite instability in colorectal cancer [Abstract]. Proc Am Assoc Cancer Res 1996;37:547.
11. Honchel R, Hailing KC, Thibodeau SN. Genomic instability in neoplasia. Semin Cell Biol 1995;6:45-52.
12. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, Perucho M. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 1993;363:558-61.
13. Jen J, Kim H, Piantadosi S, et al. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N Engl J Med 1994; 331:213-21.
14. Kern SE, Fearon ER, Tersmette KWF, et al. Clinical and pathological associations with allelic loss in colorectal carcinoma. JAMA 1989;261:3099-103.
15. Laurent-Puiz P, Olschwang S, Delattre O, et al. Survival and acquired genetic alterations in colorectal cancer. Gastroenterology 1992;102:1136-41.
16. Lothe RA, Peltomaki P, Meling GI, et al. Genomic instability in colorectal cancer; relationship to clinicopathologic variables and family history. Cancer Res 1993;53:5849-52.
17. Mao L, Lee DJ, Tockman MS, Erozan YS, Askin F, Sidransky D. Microsatellite alterations as clonal markers for the detection of human cancer. Proc Natl Acad Sci USA 1994;91:9871-5.
18. Nagorney DM. Hepatic resection for metastases from colorectal cancer. Probl Gen Surg 1987;4:83-92.
19. Offerhaus GJA, De Feyter EP, Cornelisse CJ, et al. The relationship of DNA aneuploidy to molecular genetic alterations in colorectal carcinoma. Gastroenterology 1992;102:1612-9.
20. Parker SL, Tong T, Bolden S, Wingo PA. Cancer statistics: 1996. CA Cancer J Clin 1996;46:5-27.
21. Peltomaki P, Aaltonen LA, Sistonen P, et al. Genetic mapping of a locus predisposing to human colorectal cancer. Science 1993;260:810-2.
22. Remvikos Y, Tominaga O, Hammel P, et al. Increased p53 protein content of colorectal tumours correlates with poor survival. Br J Cancer 1992;66:758-64.
23. Rosen CB, Nagorney DM, Taswell HF, et al. Perioperative blood transfusion and determinants of survival after liver resection for metastatic colorectal carcinoma. Ann Surg 1992;216:493-505.
24. SAS Institute Inc. SAS/STAT user's guide. Version 6, 4th ed, vol 1. Cary, NC: SAS Institute Inc, 1989.
25. Solomon E, Voss R, Hall V, et al. Chromosome 5 allelle loss in human colorectal carcinomas. Nature 1987;328:616-9.
26. Sun X-F, Carstensen JM, Zhang H, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992;340:1369-73.
27. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science 1993;260:816-9.
28. Vogelstein B, Fearon ER, Hamilton SR, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
29. Vogelstein B, Fearon ER, Kern SE, et al. Allelotype of colorectal carcinomas. Science 1989;244:207-11.
30. Yamaguchi A, Kurosaka Y, Fushida S, et al. Expression of p53 in colorectal cancer and its relationship to short term prognosis. Cancer 1992;70:2778-84.
31. Yin Y, Trainsky MA, Bischoff FZ, Strong LC, Wahl GM. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell 1992; 70:937-48.